CRISPR Therapeutics Target of Unusually Large Options Trading (NASDAQ:CRSP)
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) saw unusually large options trading on Tuesday. Stock traders bought 13,128 call options on the stock. This is an increase of approximately 59% compared to the average volume of 8,282 call options. Insiders Place Their Bets In other news, CEO Samarth Kulkarni sold 15,000 shares of the […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) saw unusually large options trading on Tuesday. Stock traders bought 13,128 call options on the stock. This is an increase of approximately 59% compared to the average volume of 8,282 call options. Insiders Place Their Bets In other news, CEO Samarth Kulkarni sold 15,000 shares of the […]
